GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Shanghai Chenguang Medical Technologies Co Ltd (BJSE:430300) » Definitions » Intrinsic Value: Projected FCF

Shanghai Chenguang Medical Technologies Co (BJSE:430300) Intrinsic Value: Projected FCF : ¥2.19 (As of Jun. 03, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai Chenguang Medical Technologies Co Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-03), Shanghai Chenguang Medical Technologies Co's Intrinsic Value: Projected FCF is ¥2.19. The stock price of Shanghai Chenguang Medical Technologies Co is ¥7.57. Therefore, Shanghai Chenguang Medical Technologies Co's Price-to-Intrinsic-Value-Projected-FCF of today is 3.5.

The historical rank and industry rank for Shanghai Chenguang Medical Technologies Co's Intrinsic Value: Projected FCF or its related term are showing as below:

BJSE:430300' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.82   Med: 2.53   Max: 451
Current: 3.46

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Shanghai Chenguang Medical Technologies Co was 451.00. The lowest was 1.82. And the median was 2.53.

BJSE:430300's Price-to-Projected-FCF is ranked worse than
79.82% of 1913 companies
in the Industrial Products industry
Industry Median: 1.53 vs BJSE:430300: 3.46

Shanghai Chenguang Medical Technologies Co Intrinsic Value: Projected FCF Historical Data

The historical data trend for Shanghai Chenguang Medical Technologies Co's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Chenguang Medical Technologies Co Intrinsic Value: Projected FCF Chart

Shanghai Chenguang Medical Technologies Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.94 3.24 3.57 2.84

Shanghai Chenguang Medical Technologies Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.19 2.63 3.01 2.84 2.19

Competitive Comparison of Shanghai Chenguang Medical Technologies Co's Intrinsic Value: Projected FCF

For the Electrical Equipment & Parts subindustry, Shanghai Chenguang Medical Technologies Co's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Chenguang Medical Technologies Co's Price-to-Projected-FCF Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Shanghai Chenguang Medical Technologies Co's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Chenguang Medical Technologies Co's Price-to-Projected-FCF falls into.



Shanghai Chenguang Medical Technologies Co Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Shanghai Chenguang Medical Technologies Co's Free Cash Flow(6 year avg) = ¥-4.59.

Shanghai Chenguang Medical Technologies Co's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*-4.58688+279.925*0.8)/82.322
=2.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Chenguang Medical Technologies Co  (BJSE:430300) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Shanghai Chenguang Medical Technologies Co's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=7.57/2.1898312683305
=3.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Chenguang Medical Technologies Co Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Chenguang Medical Technologies Co's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Chenguang Medical Technologies Co (BJSE:430300) Business Description

Traded in Other Exchanges
N/A
Address
No. 1269, Huaqing Road, Qingpu District, Shanghai, CHN, 201707
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.

Shanghai Chenguang Medical Technologies Co (BJSE:430300) Headlines

No Headlines